Characterization of glomerular diseases using proteomic analysis of laser capture microdissected glomeruli

Modern Pathology

Volumn 25, Issue 5, 2012, Pages 709-721

  Satoskar, Anjali A ^a   Shapiro, John P ^a   Bott, Cherri N ^a   Song, Huijuan ^a   Nadasdy, Gyongyi M ^a   Brodsky, Sergey V ^a   Hebert, Lee A ^a   Birmingham, Daniel J ^a   Nadasdy, Tibor ^a   Freitas, Michael A ^a   Rovin, Brad H ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

glomerular disease; kidney; laser capture microdissection; lupus; mass spectrometry; proteomics

Indexed keywords

COMPLEMENT; FIBRONECTIN; FIBULIN; PROTEOME;

ADULT; ARTICLE; BIOACCUMULATION; CELL METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIAGNOSTIC PROCEDURE; FEMALE; FIBRONECTIN GLOMERULOPATHY; GLOMERULOPATHY; GLOMERULUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; LASER CAPTURE MICRODISSECTION; LIQUID CHROMATOGRAPHY; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; MOLECULAR BIOLOGY; PATHOGENESIS; PODOCYTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEIN PROCESSING; PROTEOMICS; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; TANDEM MASS SPECTROMETRY;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETIC NEPHROPATHIES; FEMALE; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; HUMANS; KIDNEY DISEASES; KIDNEY GLOMERULUS; LASER CAPTURE MICRODISSECTION; LUPUS NEPHRITIS; MALE; MEMBRANE PROTEINS; PEDIGREE; PEPTIDE MAPPING; PROTEOMICS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 84860440770     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2011.205     Document Type: Article

References (51)

1. Edgley AJ, Gow RM, Kelly DJ. Laser-capture microdissection and pressure catapulting for the analysis of gene expression in the renal glomerulus. Meth Mol Biol 2010;611:29-40.
2. Kohda Y, Murakami H, Moe OW, et al. Analysis of segmental renal gene expression by laser capture microdissection. Kidney Int 2000;57:321-331. (Pubitemid 30227781)
3. Schmid H, Henger A, Cohen CD, et al. Gene expression profiles of podocyte-associated molecules as diagnostic markers in acquired proteinuric diseases. J Am Soc Nephrol 2003;14:2958-2966. (Pubitemid 37305659)
4. Rudnicki M, Eder S, Perco P, et al. Gene expression profiles of human proximal tubular epithelial cells in proteinuric nephropathies. Kidney Int 2007;71: 325-335. (Pubitemid 46227092)
5. Bennett MR, Czech KA, Arend LJ, et al. Laser capture microdissection- microarray analysis of focal segmental glomerulosclerosis glomeruli. Nephron Exp Nephrol 2007;107:e30-e40. (Pubitemid 47355799)
6. Peterson KS, Huang JF, Zhu J, et al. Characterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional profiles of laser-captured glomeruli. J Clin Invest 2004;113:1722-1733. (Pubitemid 39071664)
7. Potthoff SA, Sitek B, Stegbauer J, et al. The glomerular proteome in a model of chronic kidney disease. Proteomics Clin Appl 2008;2:1127-1139.
8. Xu BJ, Shyr Y, Liang X, et al. Proteomic patterns and prediction of glomerulosclerosis and its mechanisms. J Am Soc Nephrol 2005;16:2967-2975. (Pubitemid 44743494)
9. Miyamoto M, Yoshida Y, Taguchi I, et al. In-depth proteomic profiling of the normal human kidney glomerulus using two-dimensional protein prefractionation in combination with liquid chromatographytandem mass spectrometry. J Proteome Res 2007;6:3680-3690. (Pubitemid 47522757)
10. Sitek B, Potthoff S, Schulenborg T, et al. Novel approaches to analyse glomerular proteins from smallest scale murine and human samples using DIGE saturation labelling. Proteomics 2006;6:4337-4345. (Pubitemid 44277035)
11. Yoshida Y,MiyamotoM, Taguchi I, et al. Human kidney glomerulus proteome and biomarker discovery of kidney diseases. Proteomics Clin Appl 2008;2:420-427. (Pubitemid 351425369)
12. Gemperle O, Neuweiler J, Reutter FW, et al. Familial glomerulopathy with giant fibrillar (fibronectin-positive) deposits: 15-year follow-up in a larger kindred. Am J Kidney Dis 1996;28:668-675. (Pubitemid 26363892)
13. Strom EH, Banfi G, Krapf R, et al. Glomerulopathy associated with predominant fibronectin deposits: a newly recognized hereditary disease. Kidney Int 1995;48:163-170.
14. Hildebrandt F, Strahm B, Prochoroff A, et al. Glomerulopathy associated with predominant fibronectin deposits: exclusion of the genes for fibronectin, villin and desmin as causative genes. Am J Med Gen 1996;63:323-327.
15. Mazzucco G, Maran E, Rollino C, et al. Glomerulonephritis with organized deposits: a mesangiopathic, not immune complex-mediated disease? A pathologic study of two cases in the same family. Hum Path 1992;23:63-68.
16. Sekiguchi K, Siri A, Zardi L, et al. Differences in domain structure between human fibronectins isolated from plasma and from culture supernatants of normal and transformed fibroblasts. Studies with domainspecific antibodies. J Biol Chem 1985;260:5105-5114. (Pubitemid 15031513)
17. Zhao HL, Lai FM, Tong PC, et al. Clinicopathologic characteristics of nodular glomerulosclerosis in Chinese patients with type 2 diabetes. Am J Kidney Dis 2004;44:1039-1049. (Pubitemid 39556484)
18. Ding L, Zhao M, Zou W, et al. Mycophenolate mofetil combined with prednisone for diffuse proliferative lupus nephritis: a histopathological study. Lupus 2004;13:113-118. (Pubitemid 38222356)
19. Oomura A, Nakamura T, Arakawa M, et al. Alterations in the extracellular matrix components in human glomerular diseases. Virchows Arch A Pathol Anat Histopathol 1989;415:151-159. (Pubitemid 19170564)
20. Tuttle SE, Sharma HM, Bay WH, et al. A unique familial lobular glomerulopathy. Arch Pathol Lab Med 1987;111:726-731. (Pubitemid 17127180)
21. Xu H, Freitas MA. MassMatrix: a database search program for rapid characterization of proteins and peptides from tandem mass spectrometry data. Proteomics 2009;9:1548-1555.
22. Tucci M, Lombardi L, Richards HB, et al. Overexpression of interleukin-12 and T helper 1 predominance in lupus nephritis. Clin Exp Immunol 2008;154:247-254.
23. Xu H, Freitas MA. Monte Carlo simulation-based algorithms for analysis of shotgun proteomic data. J Proteome Res 2008;7:2605-2615.
24. Xu H, Freitas MA. A mass accuracy sensitive probability based scoring algorithm for database searching of tandem mass spectrometry data. BMC Bioinformatics 2007;8:133.
25. Lundgren DH, Hwang SI, Wu L, et al. Role of spectral counting in quantitative proteomics. Exp Rev Proteomics 2010;7:39-53.
26. Carvalho PC, Hewel J, Barbosa VC, et al. Identifying differences in protein expression levels by spectral counting and feature selection. Genet Mol Res 2008;7:342-356.
27. Liu H, Sadygov RG, Yates III JR. A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal Chem 2004;76: 4193-4201. (Pubitemid 38943698)
28. Zhang B, Chambers MC, Tabb DL. Proteomic parsimony through bipartite graph analysis improves accuracy and transparency. J Proteome Res 2007;6:3549-3557. (Pubitemid 47522746)
29. Zhang B, VerBerkmoes NC, Langston MA, et al. Detecting differential and correlated protein expression in label-free shotgun proteomics. J Proteome Res 2006;5:2909-2918. (Pubitemid 44749209)
30. Castelletti F, Donadelli R, Banterla F, et al. Mutations in FN1 cause glomerulopathy with fibronectin deposits. Proc Natl Acad Sci USA 2008;105:2538-2543. (Pubitemid 351520549)
31. de Vega S, Iwamoto T, Yamada Y. Fibulins: multiple roles in matrix structures and tissue functions. Cell Mol Life Sci 2009;66:1890-1902.
32. Singh U, Sun T, Larsson T, et al. Expression and functional analysis of fibulin-1 (Fbln1) during normal and abnormal placental development of the mouse. Placenta 2006;27:1014-1021. (Pubitemid 44204027)
33. Roselli S, Gribouval O, Boute N, et al. Podocin localizes in the kidney to the slit diaphragm area. Am J Pathol 2002;160:131-139. (Pubitemid 34052274)
34. Birmingham DJ, Irshaid F, Nagaraja HN, et al. The complex nature of serum C3 and C4 as biomarkers of lupus renal flare. Lupus 2010;19:1272-1280.
35. Lai KN, Lo ST, Lai FM. Immunohistochemical study of the membrane attack complex of complement and S-protein in idiopathic and secondary membranous nephropathy. Am J Pathol 1989;135:469-476. (Pubitemid 19246205)
36. Ostergaard J, Hansen TK, Thiel S, et al. Complement activation and diabetic vascular complications. Clin Chim Acta 2005;361:10-19. (Pubitemid 41382606)
37. Rovin BH, McKinley AM, Birmingham DJ. Can we personalize treatment for kidney diseases? Clin J Am Soc Nephrol 2009;4:1670-1676.
38. Bing DH, Almeda S, Isliker H, et al. Fibronectin binds to the C1q component of complement. Proc Natl Acad Sci USA 1982;79:4198-4201. (Pubitemid 12035105)
39. Pearlstein E, Sorvillo J, Gigli I. The interaction of human plasma fibronectin with a subunit of the first component of complement, C1q. J Immunol 1982; 128:2036-2039. (Pubitemid 12086482)
40. Vollmer M, Jung M, Ruschendorf F, et al. The gene for human fibronectin glomerulopathy maps to 1q32, in the region of the regulation of complement activation gene cluster. Am J Hum Genet 1998;63:1724-1731. (Pubitemid 30415735)
41. Vollmer M, Kremer M, Ruf R, et al. Molecular cloning of the critical region for glomerulopathy with fibronectin deposits (GFND) and evaluation of candidate genes. Genomics 2000;68:127-135.
42. Miyazaki M, Abe K, Koji T, et al. Intraglomerular C3 synthesis in human kidney detected by in situ hybridization. J Am Soc Nephrol 1996;7:2428-2433. (Pubitemid 27465950)
43. Nakorchevsky A, Hewel JA, Kurian SM, et al. Molecular mechanisms of chronic kidney transplant rejection via large-scale proteogenomic analysis of tissue biopsies. J Am Soc Nephrol 2010;21:362-373.
44. Godyna S, Mann DM, Argraves WS. A quantitative analysis of the incorporation of fibulin-1 into extracellular matrix indicates that fibronectin assembly is required. Matrix Biol 1995;14:467-477.
45. Balbona K, Tran H, Godyna S, et al. Fibulin binds to itself and to the carboxyl-terminal heparin-binding region of fibronectin. J Biol Chem 1992;267:20120-20125.
46. Miyamoto S, Katz BZ, Lafrenie RM, et al. Fibronectin and integrins in cell adhesion, signaling, and morphogenesis. Ann NY Acad Sci 1998;857:119-129. (Pubitemid 28526261)
47. Twal WO, Czirok A, Hegedus B, et al. Fibulin-1 suppression of fibronectin-regulated cell adhesion and motility. J Cell Sci 2001;114:4587-4598. (Pubitemid 34082877)
48. Lomas AC, Mellody KT, Freeman LJ, et al. Fibulin-5 binds human smooth-muscle cells through alpha5beta1 and alpha4beta1 integrins, but does not support receptor activation. Biochem J 2007;405:417-428. (Pubitemid 47172038)
49. Musante L, Candiano G, Bruschi M, et al. Characterization of plasma factors that alter permeability to albumin within isolated glomeruli. Proteomics 2002;2:197-205. (Pubitemid 34273088)
50. Schieren G, Rumberger B, Klein M, et al. Gene profiling of polycystic kidneys. Nephrol Dial Transplant 2006;21:1816-1824. (Pubitemid 43985708)
51. Lee NV, Rodriquez-Manzaneque JC, Thai SN, et al. Fibulin-1 acts as a cofactor for the matrix metalloprotease ADAMTS-1. J Biol Chem 2005;280:34796-34804. (Pubitemid 41504613)